We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TTOO market cap is 25.87M. The company's latest EPS is USD -2.8648 and P/E is -0.52.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.96M | 1.47M | 1.68M | 2.06M | 1.95M |
| Operating Income | -13.05M | -13.61M | -9.32M | -12.6M | -9.58M |
| Net Income | -6.35M | -15.43M | -10.34M | -13.53M | -8.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 8.34M | 18.13M | 28.06M | 22.31M | 7.19M |
| Operating Income | -52.06M | -41.36M | -42.97M | -55.2M | -49.66M |
| Net Income | -59.01M | -46.79M | -49.24M | -62.33M | -50.08M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 37.13M | 43.28M | 34.8M | 24.76M | 21.72M |
| Total Liabilities | 73.55M | 62.52M | 62.83M | 62.53M | 27.62M |
| Total Equity | -36.42M | -19.24M | -28.04M | -37.77M | -5.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 28.49M | 79.08M | 60.54M | 34.33M | 34.8M |
| Total Liabilities | 62.49M | 70.35M | 73.44M | 73.98M | 62.83M |
| Total Equity | -34.01M | 8.73M | -12.9M | -39.66M | -28.04M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -25.33M | -38.72M | -48.14M | -11.68M | -20.92M |
| Investing | -153k | -166k | -192k | N/A | N/A |
| Financing | 30.24M | 51.88M | 52.69M | 2.2M | 9.48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -45.36M | -43.22M | -38.87M | -50.63M | -48.14M |
| Investing | -761k | -36.26M | 24.79M | 9.66M | -192k |
| Financing | 6.35M | 85.61M | 20.54M | 29.05M | 52.69M |
| Market Cap | 25.87M |
| Price to Earnings Ratio | -0.52 |
| Price to Sales Ratio | 3.6 |
| Price to Cash Ratio | 1.65 |
| Price to Book Ratio | -0.92 |
| Dividend Yield | - |
| Shares Outstanding | 17.48M |
| Average Volume (1 week) | 551.54k |
| Average Volume (1 Month) | 294.96k |
| 52 Week Change | -82.21% |
| 52 Week High | 8.6499 |
| 52 Week Low | 1.38 |
| Spread (Intraday) | 0.08 (5.13%) |
| Company Name | T2 Biosystems Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.t2biosystems.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
